Liminatus Pharma, Inc.Liminatus Pharma, Inc.Liminatus Pharma, Inc.

Liminatus Pharma, Inc.

No trades
See on Supercharts
Market capitalization
‪71.24 M‬USD
−0.40USD
‪−2.90 M‬USD
0.00USD
‪174.48 K‬
Beta (1Y)
−0.41
Employees (FY)
3
Change (1Y)
0
Revenue / Employee (1Y)
0.00USD
Net income / Employee (1Y)
‪−968.10 K‬USD

About Liminatus Pharma, Inc.


CEO
Chris Kim
Headquarters
La Palma
Founded
2020
FIGI
BBG01HVYG111
Liminatus Pharma, Inc. is a pre-clinical-stage immuno-oncology company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in La Palma, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as LIMN.

Frequently Asked Questions


The current price of LIMN is 8.04 USD — it has decreased by −20.16% in the past 24 hours. Watch Liminatus Pharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Liminatus Pharma, Inc. stocks are traded under the ticker LIMN.
LIMN stock has fallen by −13.08% compared to the previous week, the month change is a −13.08% fall, over the last year Liminatus Pharma, Inc. has showed a −13.08% decrease.
LIMN stock is 67.55% volatile and has beta coefficient of −0.41. Track Liminatus Pharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is Liminatus Pharma, Inc. there?
Yes, you can track Liminatus Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
LIMN net income for the last quarter is ‪−868.31 K‬ USD, while the quarter before that showed ‪−642.90 K‬ USD of net income which accounts for −35.06% change. Track more Liminatus Pharma, Inc. financial stats to get the full picture.
No, LIMN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 3, 2025, the company has 3 employees. See our rating of the largest employees — is Liminatus Pharma, Inc. on this list?
Like other stocks, LIMN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Liminatus Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.